OR13C2

Across TCGA pan-cancer cohorts, OR13C2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of OR13C2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR13C2 RNA is repressed in tumor relative to normal tissue. In most cancer types OR13C2 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and KICH are the cancer types where OR13C2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR13C2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.045	<.001	11	view →
THCA	Male	III,IV	−0.095	.044	2	view →
KICH	Male	All	−0.048	.004	2	view →
KIRP	Male	III,IV	−0.055	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

OR13C2–KIRC

Open the KIRC breakdown →